Idiopathic Short Stature clinical trials

Explore recruiting idiopathic short stature clinical trials.

Recruiting idiopathic short stature studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Idiopathic Short Stature trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Randomized, Controlled, Multicenter Study of Vosoritide in Children With Idiopathic Short Stature

Germany, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Multicenter Interventional Study Somatrogon Impact on Outcomes in Naive Small for Gestational Age or Idiopathic Short Stature paediatric patients compared with daily growth hormone

Greece, Poland, France, Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

A study evaluating the safety and efficacy of once-weekly dosing of somapacitan in a basket study design in paediatric participants with short stature either born small of gestational age or with Turner syndrome, Noonan syndrome or idiopathic short stature

Netherlands, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® as well as evaluating long-term safety of somapacitan in a basket study design in children with short stature either born small for gestational age or with Turner syndrome, Noonan syndrome, or idiopathic short stature

Austria, Poland, Portugal, Spain, Croatia, Italy +10 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

HighLiGHts - A Pivotal, Parallel-Arm, Phase 3, Open-Label, Active-controlled, Global, Multicenter, Randomized Basket Trial Investigating the Efficacy and Safety of Once-weekly Lonapegsomatropin Compared to Daily Somatropin in Prepubertal Children and Adolescents with Growth Failure or Short Stature due to Growth Hormone Sufficient Disorders – Turner Syndrome, SHOX Deficiency, Small for Gestational Age, and Idiopathic Short Stature

Germany, Spain, Italy, France, Romania

Therapeutic confirmatory (Phase III) EU CTIS Study details

Idiopathic Short Stature trials by city

Idiopathic Short Stature in Toronto Idiopathic Short Stature in Vancouver Idiopathic Short Stature in Montreal Idiopathic Short Stature in Calgary Idiopathic Short Stature in Edmonton Idiopathic Short Stature in Ottawa Idiopathic Short Stature in Winnipeg Idiopathic Short Stature in Quebec City Idiopathic Short Stature in Hamilton Idiopathic Short Stature in Kitchener Idiopathic Short Stature in London Idiopathic Short Stature in Halifax Idiopathic Short Stature in New York Idiopathic Short Stature in Los Angeles Idiopathic Short Stature in Chicago Idiopathic Short Stature in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease